FUND4HEALTH Archivos

Financiación para proyectos de investigación de biomedicina

FUND4HEALTH@LISTSERV.REDIRIS.ES

Opciones: Vista Forum

Use Monospaced Font
Por defecto enseñar Text Part
Esconda cabeceras de correo

Mensaje: [<< Primero] [< Prev] [Siguiente >] [Último >>]
Tema: [<< Primero] [< Prev] [Siguiente >] [Último >>]
Autor: [<< Primero] [< Prev] [Siguiente >] [Último >>]

Print Responder
X-CLX-Shades:
MLX
Content-Type:
multipart/related; boundary="_005_96522251b5cb495688862a75cd511909isciiies_"; type="multipart/alternative"
x-ms-exchange-messagesentrepresentingtype:
1
References:
Date:
Mon, 3 Nov 2025 15:55:14 +0000
Reply-To:
Internacionales <[log in para visualizar]>
Approved-By:
Delivered-To:
Message-ID:
MIME-Version:
1.0
Subject:
Emisor:
Internacionales <[log in para visualizar]>
x-originating-ip:
[10.22.146.254]
Sender:
Financiación para proyectos de investigación de biomedicina <[log in para visualizar]>
X-Proofpoint-Spam-Details-Enc:
AW1haW4tMjUxMTAzMDE0MyBTYWx0ZWRfX67HF88oOuHmA KHG7TUzjXllXRiQf+62T13F8QJo8JbZ/0FawUqorHFiSj+Haeg1ClCAIoJCizl0Ha2sMVWrN0/O Wl9t/6KxQzQrZiozTiG6SzR/9b4+JgdMvwR7k+EhpBGPj+4EoS74nfB/93B2eEN9+uHqnVE+36d t+qFd3m2Kr0x9nS2/TOrUUFQsa0rNaqMVXdfoypqXZtfxfOVJvOT4I1uXyPXU/mUEWThFGy8JSf G3uQFLwh3CDjMwozkCRXema/k8W/Di/yhCA21vbD1FT74XhRvCt8IgPRsjSB6Tvnvm77w/ZChIV TEj3PfYkvGeSlVgELNURADe0d4bVACs4w2Xtox1ilAhjDQ+BLsQPPisuYGnKHEFCCLXhRUlEXwN ZmU2ZKB/Lzmya/wwu6EdAXnULd08Yrach4ZMspCANlYtLSeLcvmZ9SIIdmI68S4AKDdMQ8xOEb5 lbcnP0KGK5bpC+plWtA==
x-ms-exchange-sharedmailbox-routingagent-processed:
True
X-Proofpoint-Spam-Details:
rule=politica_listserv_notspam policy=politica_listserv score=0 bulkscore=0 phishscore=0 priorityscore=48 impostorscore=0 clxscore=173 lowpriorityscore=0 suspectscore=0 adultscore=0 malwarescore=0 spamscore=0 classifier=typeunknown authscore=0 authtc= authcc= route=internal adjust=0 reason=mlx scancount=1 engine=8.22.0-2510240001 definitions=main-2511030143 domainage_hfrom=3077
Thread-Topic:
Boletín de oportunidades de financiación in ternacional Octubre 2025
X-MS-Has-Attach:
yes
Thread-Index:
AdxM2Pk/doGSinanQiabcdzEPeF6KQAAFp8QAAAiNSAAABM0gA==
Accept-Language:
es-ES, en-US
X-Authority-Analysis:
v=2.4 cv=e6cLiKp/ c=1 sm=1 tr=0 ts=6908d050 cx=c_pps a=ZNXWS+81oLEfKyJbms980Q==:117 a=ZNXWS+81oLEfKyJbms980Q==:17 a=7E+Lg0hS2erdyBn295RJLQjl35E=:19 a=xqWC_Br6kY4A:10 a=3vVrA2CgOLoA:10 a=6UeiqGixMTsA:10 a=5KLPUuaC_9wA:10 a=JyWEw40TUO5AK6tc77iI:22 a=tJurmUpOAAAA:8 a=vp7Sm8Z0ikkYV3yQ1AIA:9 a=QEXdDO2ut3YA:10 a=yMhMjlubAAAA:8 a=SSmOFEACAAAA:8 a=xqHU6d7Wri8v4rCczw4A:9 a=Cvd_lxEAE1HYDpgy:21 a=gKO2Hq4RSVkA:10 a=UiCQ7L4-1S4A:10 a=hTZeC7Yk6K0A:10 a=frz4AuCg-hUA:10 a=lqcHg5cX4UMA:10 a=HXjIzolwW10A:10 a=T6a71-JsGAwA:10 a=KQqxNPgzF0kA:10 a=VEiTNn8F7TgA:10 a=3GBSdMd2x-60a6AsME70:22 a=P8gMff4ppgpy92pg1mm4:22
X-Proofpoint-GUID:
DWGR-fI0feiEJNZ8QmkSUf6u0lfZ0lfJ
X-CLX-Response:
1TFkXGx0ZEQpMehceEhEKWUQXYXh9aUdJfk1HUx0RClhYF21uTBNyZUJgX0N pEQp4ThdvQmccY1BnXUVHcxEKQ0gXBxsfEhEKQ1kXBxgfGBEKQ0kXGgQaGhoRCllNF2dmchEKWU kXGnEaEBp3BhsfGXEZGRAadwYYGgYaEQpZXhdobnkRCklGF1hPTkNYQ1l1GHVCRVleT04RCklHF 3hPTREKQ04Xbn1teAdMYxpMT0NvYGRwEntHQXl/TBxfGkZMcBpGTGARClhcFx8EGgQeGxoFGxoE EhoEGxkeBBkeEBseGh8aEQpeWRdNekR+WBEKTVwXHhocEQpMWhdpa2lNTU0RCkxGF29ra2Nsa2s RCkJPF2Bha0hbZUkYb0RLEQpDWhcbEx8EGBkeBB8TBBIaEQpCXhcbEQpEXhcYEQpESRcbEQpCRR d6fhwcbGVAWmEaYBEKQk4Xb0JnHGNQZ11FR3MRCkJMF21uTBNyZUJgX0NpEQpCbBduGUhyHF5oX HNTXhEKQkAXZGBOeENcR01YbUQRCkJYF2FvE2xpXnl8Q3lzEQpaWBceEQp5QxdnbBlYWVJbYF5d ehEKWUsXGRodHREKcGgXbmlHHGR8GFtvT2AQGhEKcGgXYXJtZWhrTgFrY3MQGhEKcGgXZU5FSXh GWGdSQVoQGhEKcGgXbBJuYmJlb05dZm0QGhEKcGgXYk5vbGlCAVlJfxkQGhEKcGgXbB4bXmJDQF gBUhoQGhEKcGgXbm5rRn5LW2dCbGsQGhEKcGgXa2YFYnlLZlgFenoQGxoTEQpwfRdgSwVpWXBZZ 05dSRAZGhEKcGMXZGwbRFlce0BGR0kQGRoRCnB/F2cbaW8cb3xlaWdTEBMeEQpwXxdmYR1oQU5Y RG94HhAZGhEKcGwXZkFvYVJ7XRpecGQQGRoRCm1+FxoRClhNF0sRIA==
X-MS-TNEF-Correlator:
X-Proofpoint-ORIG-GUID:
DWGR-fI0feiEJNZ8QmkSUf6u0lfZ0lfJ
Received:
by LISTSERV.REDIRIS.ES (LISTSERV-TCP/IP release 17.0) with spool id 3622643 for [log in para visualizar]; Mon, 3 Nov 2025 16:57:08 +0100 from mx07-006a4e02.pphosted.com (mx07-006a4e02.pphosted.com [143.55.146.78]) by listserv.backend.rediris.es (Postfix) with ESMTP id 68DF32363DD for <[log in para visualizar]>; Mon, 3 Nov 2025 16:54:57 +0100 (CET) from pps.filterd (m0316692.ppops.net [127.0.0.1]) by m0316692.ppops.net (8.18.1.11/8.18.1.11) with ESMTP id 5A3FLRNs544971 for <[log in para visualizar]>; Mon, 3 Nov 2025 16:54:57 +0100 from correo.isciii.es ([195.234.59.80]) by m0316692.ppops.net (PPS) with ESMTPS id 4a6wee1aam-1 (version=TLSv1.2 cipher=ECDHE-RSA-AES256-GCM-SHA384 bits=256 verify=NOT) for <[log in para visualizar]>; Mon, 03 Nov 2025 16:54:56 +0100 (CET) from frigg.isciii.es (10.22.146.161) by frigg.isciii.es (10.22.146.161) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.2.1748.10; Mon, 3 Nov 2025 16:55:14 +0100 from frigg.isciii.es ([::1]) by frigg.isciii.es ([fe80::d982:26ba:fb57:15fa%12]) with mapi id 15.02.1748.010; Mon, 3 Nov 2025 16:55:14 +0100
In-Reply-To:
X-Proofpoint-Virus-Version:
Content-Language:
es-ES
Parts/Attachments:
text/plain (8 kB) , text/html (13 kB) , image004.png (7 kB) , image005.jpg (8 kB)

ATOM RSS1 RSS2